29th Jan 2008 11:00
AGI Therapeutics plc29 January 2008 AGI Therapeutics plc ("AGI" or the "Company") Award of Options to Directors On 28th January, 2008, AGI awarded the following options over ordinary shares of€0.01 each in the share capital of the Company ("Ordinary Shares") with anexercise price of €1.36 in accordance with the Company's share option scheme. Director Number of options over Ordinary Resulting number of options held Shares granted John Devane 260,000 1,290,160David Young 240,000 1,168,394Mary Martin 210,000 865,596Patrick Ashe 210,000 865,596David Kelly 210,000 865,596 Contact Information: David G. KellyChief Financial Officer Adelaide ChambersPeter StreetDublin 8 Tel: +353 1 449 3254 Ends This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai